3,162
Views
23
CrossRef citations to date
0
Altmetric
Original Article

High Norwegian prostate cancer mortality: evidence of over-reporting

ORCID Icon, , ORCID Icon, , &
Pages 122-128 | Received 18 Jan 2017, Accepted 17 Dec 2017, Published online: 11 Jan 2018

References

  • Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomarkers Prev. 2016;25:16–27.
  • Kvale R, Auvinen A, Adami HO, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;99:1881–1887.
  • Percy C, Stanek E, 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981;71:242–250.
  • Alfsen GC, Lyckander LG, Lindboe AW, et al. [Quality control of deaths in hospitals]. Tidsskr nor Laegeforen. 2010;130:476–479.
  • Johansson LA, Westerling R. Comparing hospital discharge records with death certificates: can the differences be explained?. J Epidemiol Community Health. 2002;56:301–308.
  • Maudsley G, Williams EM. 'Inaccuracy' in death certification-where are we now? J Public Health Med. 1996;18:59–66.
  • Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer-part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst. 1999;91:1025–1032.
  • Godtman R, Holmberg E, Stranne J, et al. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm. Scand J Urol Nephrol. 2011;45:226–232.
  • Makinen T, Karhunen P, Aro J, et al. Assessment of causes of death in a prostate cancer screening trial. Int J Cancer. 2008;122:413–417.
  • Hernes E, Harvei S, Glattre E, et al. High prostate cancer mortality in Norway: influence of Cancer Registry information? APMIS. 2005;113:542–549.
  • Hernes E, Johansson LA, Fossa SD, et al. High prostate cancer mortality in Norway evaluated by automated classification of medical entities. Eur J Cancer Prev. 2008;17:331–335.
  • Havlik RJ, Rosenberg HM. The quality and application of death records of older patients. New York: Oxford University Press; 1992.
  • Skyrud KD, Bray F, Moller B. A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis. Int J Cancer. 2014;135:196–203.
  • R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
  • Cancer Registry of Norway. Årsrapport 2004-2013 [Norwegian]. 2014. Available from: https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/2015/aarsrapport_2015_prostata.pdf
  • Larsen IK, Myklebust TA, Robsahm TE, et al. Spesialnummer: Kreft i Norges fylker 1954–2013. I Cancer in Norway 2013-Cancer incidence, mortality, survival and prevalence in Norway. 2015. p. 181.
  • Bakken IJ, Ellingsen CL, Pedersen AG, et al. Comparison of data from the Cause of Death Registry and the Norwegian Patient Register. Tidsskr nor Laegeforen. 2015;135:1949–1953.
  • Pedersen AG, Ellingsen CL. Data quality in the Causes of Death Registry. Tidsskr nor Laegeforen. 2015;135:768–770.
  • Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol. 2000;163:519–523.
  • Fall K, Stromberg F, Rosell J, et al. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol. 2008;42:352–357.
  • Maattanen L, Auvinen A, Stenman UH, et al. European randomized study of prostate cancer screening: first-year results of the Finnish trial. Br J Cancer. 1999;79:1210–1214.
  • Turner EL, Metcalfe C, Donovan JL, et al. Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee. Br J Cancer. 2016;115:90–94.
  • Barry MJ, Andriole GL, Culkin DJ, et al. Ascertaining cause of death among men in the prostate cancer intervention versus observation trial. Clinical Trials. 2013;10:907–914.